The regulation of p53 function: Steiner award lecture

International Journal of Cancer

Volumn 57, Issue 5, 1994, Pages 623-627

  Lane, D P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER; CONFERENCE PAPER; DNA BINDING; DNA DAMAGE; HUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMAL; DNA DAMAGE; DNA-BINDING PROTEINS; HUMAN; NEOPLASMS; PROTEIN P53;

EID: 0028231086     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910570502     Document Type: Article

References (55)

1. Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?
2. Abnormal expression of wild type p53 in normal cells of a cancer family patient
3. Abberant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
4. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines
5. Immunoassay of the cellular protein p53 in mouse and human cell lines
6. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer
7. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis
8. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein
9. p53 expression in breast cancer
10. Thymocyte apoptosis is induced hyp53‐dependent and independent pathways
11. Detection of transformation‐related antigen in chemically induced sarcomas and other transformed cells of the moase
12. Mice deficient for p53 are develop men tally normal but susceptible to spontaneous tumours
13. Wafi, a potential mediator of p53 tumor suppression
14. The biology of simian virus 40 and polyoma virus
15. Induction of nuclear accumulation of the tumor‐suppressor protein p53 by DNA‐damaging agents
16. Interaction between SV40 T antigen and DNA polymerase
17. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
18. High levels of p53 protein in UV irradiated human skin
19. Genetic background alters the spectrum of tumors that develop in p53‐deticient mice
20. p53 mutations in human cancer
21. Regulation of the specific DNA binding function of p53
22. Activation of the cryptic DNA binding function of mutant forms of p53
23. Increased expression of mutant forms of p53 oncogene in primary lung cancer
24. Association of overexpression of tumour suppressor protein p53 with rapid cell proliferation and poor prognosis in node‐negative breast cancer patients
25. Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins
26. Participation of p53 protein in the cellular response to DNA damage
27. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia‐telangiectasia
28. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors
29. Wild‐type p53 is a cell cycle checkpoint determinant following irradiation
30. p53 guardian of the genome
31. Cancer. A death in the life of p53 [news comment]
32. T‐antigen is bound to host protein in SV40‐transformed cells
33. Monoclonal antibody analysis of the SV40 large Tantigen‐p53 complex
34. p53 is required for radiation‐induced apoptosis in mouse thymocytes [see comments]
35. Differential induction of transcriptionally actire p53 following UV or ionising radiation: defects in chromosome instability syndromes
36. ras‐induced hyperplasia occur with mutation of p53, but an activated ras and mye together can induce carcinoma without p53 mutation
37. IV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells
38. Primary rat cells expressing a hybrid polyomavirus‐simian virus 40 large T antigen have altered growth properties
39. P53 expression and prognosis in gastric carcinoma
40. The role of p53 in spontanecous and radiation‐induced apoptosis in the gastrointestinal tract of normal and p53 deficient mice
41. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in E. Coli
42. The transcript ional transactivation function of wild‐type p53 is inhibited by SV40 large T‐antigen and by HPV‐16 E6 oncoprotein
43. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53‐mediated transactivation
44. Identification and characterization of multiple mdm‐2 froteins and mdm‐2‐p53 protein complexes
45. Post‐translational regulation of the 54K cellular tumor antigen in normal and transformed cells
46. Structure and function of simian virus 40 large
47. p53 mutations in colorectal cancer
48. Adenoyirus EIb‐58Kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54Kd cellular protein in transformed cells
49. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
50. Mutant conformation of p53; precise epitope mapping using a filamentous plugs epitope library
51. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers
52. Regulation of p53 protein expression in human breast cancer cell lines
53. An immunochemical analysis of human p53: new monoclonal antibodies and epitope mapping using recombinant p53
54. Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique
55. Biological consequences of the genetic changes which occur during human colorectal carcinogenesis